{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:30:52Z","timestamp":1792092652207,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijrobp.2022.11.010","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T01:49:09Z","timestamp":1676944149000},"page":"813-816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["DCIS Update: Escalation or De-escalation? Boost, Fractionation, and Omission of Radiation"],"prefix":"10.1016","volume":"115","author":[{"given":"Jaroslaw T.","family":"Hepel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Loap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fourquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia M.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.11.010_bib0001","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: Long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0003","doi-asserted-by":"crossref","first-page":"431\u2011440","DOI":"10.1016\/S0140-6736(22)01246-6","article-title":"Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07\/TROG 07.01): A randomised, factorial, multicentre, open-label, phase 3 study","volume":"400","author":"Chua","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0004","doi-asserted-by":"crossref","first-page":"57\u201165","DOI":"10.1016\/j.radonc.2021.09.014","article-title":"Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ","volume":"164","author":"Bourgier","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0005","doi-asserted-by":"crossref","first-page":"1060\u20111068","DOI":"10.1001\/jamaoncol.2016.6948","article-title":"Association of radiotherapy boost for ductal carcinoma in situ with local control after whole-breast radiotherapy","volume":"3","author":"Moran","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0006","doi-asserted-by":"crossref","first-page":"3259\u20113265","DOI":"10.1200\/JCO.2007.11.4991","article-title":"Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial","volume":"25","author":"Bartelink","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0007","first-page":"1098\u20111107","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0008","doi-asserted-by":"crossref","first-page":"1086\u20111094","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0009","doi-asserted-by":"crossref","first-page":"513\u2011520","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0010","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00317","article-title":"Three-year outcomes with hypofractionated versus conventionally fractionated whole-breast irradiation: Results of a randomized, noninferiority clinical trial","author":"Shaitelman","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0011","doi-asserted-by":"crossref","first-page":"3604\u20113614","DOI":"10.1200\/JCO.20.01024","article-title":"Hypofractionated versus conventional fractionated radiotherapy after breast-conserving surgery in the modern treatment era: A multicenter, randomized controlled trial from China","volume":"38","author":"Wang","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0012","first-page":"1613\u20111626","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0013","doi-asserted-by":"crossref","first-page":"3615\u20113625","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: The DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0014","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.21.01083","article-title":"Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: Long-term report from NRG Oncology\/RTOG 9804","volume":"39","author":"McCormick","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0016","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial","volume":"31","author":"Donker","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0017","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","article-title":"Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial","volume":"32","author":"W\u00e4rnberg","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0018","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0019","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1200\/JCO.2005.02.9975","article-title":"Prospective study of wide excision alone for ductal carcinoma in situ of the breast","volume":"24","author":"Wong","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-013-2813-6","article-title":"Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS)","volume":"143","author":"Wong","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0021","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1200\/JCO.2009.21.8560","article-title":"Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group","volume":"27","author":"Hughes","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0022","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study","volume":"33","author":"Solin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0023","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brachy.2017.09.004","article-title":"The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation","volume":"17","author":"Shah","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0024","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated partial breast irradiation: Executive summary for the update of an ASTRO evidence-based consensus statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0025","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: Long-term results of the randomized phase III APBI-IMRT-Florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0026","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ijrobp.2022.11.010_bib0027","doi-asserted-by":"crossref","first-page":"djw256","DOI":"10.1093\/jnci\/djw256","article-title":"Multigene expression assay and benefit of radiotherapy after breast conservation in ductal carcinoma in situ","volume":"109","author":"Rakovitch","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0028","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"A biological signature for breast ductal carcinoma in situ to predict radiotherapy benefit and assess recurrence risk","volume":"24","author":"Bremer","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0029","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1158\/1078-0432.CCR-19-1152","article-title":"Validation of a ductal carcinoma in situ biomarker profile for risk of recurrence after breast-conserving surgery with and without radiotherapy","volume":"26","author":"Weinmann","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0030","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.3390\/cancers13236103","article-title":"Prognostic risk assessment and prediction of radiotherapy benefit for women with ductal carcinoma in situ (DCIS) of the breast, in a randomized clinical trial (SweDCIS)","volume":"13","author":"W\u00e4rnberg","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2022.11.010_bib0031","unstructured":"ClinicalTrials.gov. Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast (ROMANCE). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03878342. Accessed November 4, 2022."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622035246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622035246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:04:36Z","timestamp":1759745076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622035246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0360301622035246"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.11.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DCIS Update: Escalation or De-escalation? Boost, Fractionation, and Omission of Radiation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}